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Abstract 
Background: In low income countries, many patients with breast cancer present with advanced disease which is 
majorly attributed to late presentation and this is associated with poor survival rates. The aim of this study was to 
determine the magnitude of patient delay and the factors that influence, delay in seeking health care in female breast 
cancer patients.
Methods: A cross-sectional study was done between January and April 2014 at a tertiary breast unit. Female patients 
with breast cancer above the age of 18 years were interviewed. Ethical approval was obtained.
Results: In total 162 patients were recruited, the mean patient delay in months was 22.6 (SD = 26.4), median delay 
was 13 months and range was 1–127 months. 139 (89 %) patients delayed by more than 3 months after notic-
ing symptoms of breast anomaly. Patients with no social support from spouses and family were more likely to 
delay (OR = 7.1, 95 % CI 2.4–21.5, p = 0.001), those who perceived the symptoms as very serious were less likely to 
delay (OR = 0.2, 95 % CI 0.1–0.6, p = 0.007). There was a significant association between delayed presentation and 
advanced stage at presentation (p = 0.006).
Conclusion: Most women (89 %) with breast cancer delayed by more than 3 months to seek the first medical consul-
tation after noticing symptoms. Patients who had no social support from their families were more likely to delay.
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Background
Breast cancer is the second commonest non HIV-related 
cancer among women in Uganda. The majority of women 
present with advanced disease stage III and IV and the 
5 year survival rate in less than 50 % [1]. State provided 
health care services in Uganda are largely free. However, 
50 % of health care services are provided by non govern-
ment providers and charge a fee for the services. Delayed 
patient presentation refers to a prolonged interval 
between discovery of initial symptoms to presentation to 
a provider and typically defined as greater than 12 weeks 
as periods longer than this have been associated with 
poorer survival [2]. Patient delay has been associated 
with increased tumor size, more advanced stage at pres-
entation and poorer long term survival [3] and is a signif-
icant concern in middle and low income countries (LIC).
The association between patient delay and socio-demo-
graphic factors, cancer knowledge, family history and 
other factors has been widely studied [4]. However most 
of these studies are from the high and middle income 
countries and similar research focusing on LIC is limited. 
In Uganda there is only one published research study 
on this topic [5] and hence the aim of this study was to 
determine the magnitude and factors that influence 
patient delay among women with breast cancer.
Methods
A cross-sectional study was carried out at the breast 
unit of Mulago National Referral Hospital over a period 
of 4  months between January and April 2014. Female 
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patients 18  years and above with histological diagnoses 
of breast cancer were consecutively enrolled after written 
informed consent had been obtained. Patients who were 
too ill to give sufficient information were excluded from 
the study.
An adopted interviewer administered structured ques-
tionnaire [6] were used to obtain the study variables. This 
tool was pre-tested and modified before final data col-
lection was done. The variables included in data analy-
sis were: age, occupation, education level, family size, 
religion, income, marital status, health beliefs, percep-
tions, knowledge of breast cancer, clinical stage of tumor, 
social support from spouses and time delays. Social sup-
port was taken as the perception and actuality that one 
is cared for, has assistance available from other people 
(spouse, relatives and friends) and that one is part of a 
supportive social network [7]. STATA 12 statistical soft-
ware was used for data analysis. Univariate analysis was 
performed on baseline factors and magnitude of patient 
delay. Logistic regression was used for comparison of 
variables and significance was when p < 0.05.
Ethical approval was obtained from the Makerere Col-
lege of Health Sciences Research & Ethics Committee.
Results
The 162 patients studied had a mean age of 45.12 
(SD = 11.70), median age of 44 and the peak age category 
was 35–44. The majority of the patients, 142 (87.7  %) 
came from rural areas and only 20 (12.3  %) came from 
an urban setting. 139 (86 %) had clinical stage IV disease 
and 17 (10 %) had clinical stage III disease. The details of 
the characteristics of the study participants are shown in 
Table 1.
78 (48 %) patients perceived the symptoms as nothing 
serious. 71 (44 %) patients were not worried at the time 
they first noticed the symptoms of breast cancer, only 12 
(7  %) patients sought attention immediately after notic-
ing breast cancer symptoms (see Table 2).
The first symptoms noticed were a lump 86  % 
(139/162), pain 12 % (19/162) and 2 % (4/162) had abnor-
mal discharge. Even through 45 worried a lot about the 
first symptoms and 46 considered them very seriously; 
12 sought attention immediately. The mean patient 
delay was 22.6 (SD  =  26) months. Median delay was 
13 months, range was 1–127 months.
The mean patient delay was 22.6 (SD  =  26) months. 
Median delay was 13 months, range was 1–127 months. 
The majority, 139 (89  %) patients delayed by more than 
3 months after noticing symptoms while only 17 (11 %) 
patients sought attention within 3  months of noticing 
symptoms of breast cancer (see Table 3).
Table 1 Characteristics of study participants
a One missing religion, two missing marital status
b 1US dollars = 2600 Uganda shillings (July 2014)
Variable Participant distribution
Number Percentage
Age group in years
 <35 32 20
 35–44 51 32
 45–55 40 25
 >55 38 24
Religiona
 Catholic 53 33
 Muslim 16 10
 Pentecostal 37 23
 Protestant 52 32
 SDA 3 2
Employment
 Unskilled worker 36 22
 Subsistence farmer 53 33
 Formal employment 29 18
 Unemployment 44 27
Marital statusa
 Single 20 13
 Married 87 54
 Widowed 25 16
 Divorced 28 18
Number of children
 None 12 7
 1–3 82 51
 ≥4 68 42
Monthly income (shillings)b
 ≤93,750 70 43
 >93,750 91 57
Education level
 None 15 9
 Primary 54 33
 Secondary 57 35
 Tertiary 36 22
Positive history of familial breast cancer 42 26
Positive history of benign breast disease
 Yes 30 19
Manchester clinical stage
 Stage 2 6 4
 Stage 3 17 10
 Stage 4 139 86
Tumor grade
 Well differentiated 76 47
 Moderately differentiated 31 19
 Poorly differentiated 55 34
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Of the 139 who delayed, 123 (88.5  %) presented 
with stage IV and 13 (9.4  %) stage III. Mean age of 45 
(SD  =  11.8). Of the 17 who did not delay, 11 (64.7  %) 
presented with stage IV and 3 (17.7  %) stage III. Mean 
age of 45.3 (SD  =  10.8). There was a significant asso-
ciation between patient delay and lack of social support 
(OR = 7.12, 95 % CI 2.36–21.46, P = 0.001). There was 
also a significant association between delayed presenta-
tion and advanced stage at presentation (OR  =  11.18, 
95  % CI 2.01–62.13, P  =  0.006), while the associa-
tion between age, religion, marital status, occupation, 
education level, monthly income and fear of surgery and 
patient delay were not significant (see Table 4).
Discussion
We found out that the overall median delay to the first 
medical consultation was 13 months. This contrasts with 
the findings in studies done in the developed countries 
where median delay to the first medical consultations 
was found to be 14–61 days [6–8]. The median delay time 
to first medical consultation in this study was 13 months 
which is comparable to the median delay of 12  months 
reported in a study done in Uganda and published in 
2014 [4].
The majority of patients in our study presented 
3 months after noticing symptoms most likely because of 
the way they perceived the ‘seriousness’ of the symptoms, 
(p = 0.007) which is likely to be based on their awareness 
(knowledge) of breast cancer. Of the 162 patients studied, 
139 (86  %) presented with stage IV disease. This could 
be due to excessive delay that allowed the progression of 
the disease to advanced stage and is in agreement with 
other studies [4, 9–11]. The advanced stage at presen-
tation could be due to the fact that most cancer in low-
and-middle income countries (LMIC) is detected at later 
stages [12]. It is commonly assumed that this late diagno-
sis is due to populations’ lack of information and deficient 
or absent screening programmes. There was a significant 
association between patient delay and late stage at pres-
entation in the present study. The influence of delay on 
disease stage is well documented [2, 4].
The patients who lacked social support from family 
members and spouses were more likely to delay. It is also 
worth noting that even though 45 took the first cancer 
symptoms seriously, only less than third 12/45 sought 
care immediately. This is in keeping with a study done in 
Mexico in 2011 where it was mentioned that social sup-
port is crucial for materialization of the initial contact as 
well as for the community care [13]. Social support was 
taken as the perception and actuality that one is cared 
for, has assistance available from other people (spouse, 
relatives and friends) and that one is part of a supportive 
social network [7]. In a context like ours that lacks a com-
prehensive state welfare benefits, social support becomes 
even more critical. Several studies have also described 
how the patient’s concealment of symptoms may influ-
ence, delay of medical help-seeking, while discussing 
them with friends and family can facilitate the decision to 
seek medical advice [14, 15].
In the current study, patients with knowledge of avail-
able services were more likely to delay. This is in contrast 
with the findings from other studies [10, 16–18]. The 
most likely explanation here is that the likely low level of 
confidence in the accessibility of the available services.
Table 2 Perception of symptoms of breast cancer
Characteristic Participant distribution
Number Percentage
How serious symptoms were considered
 Nothing serious 78 48
 Little serious 28 17
 Moderately serious 10 6
 Very serious 46 28
Worried at that time
 No 71 44
 A little 33 20
 Some 13 8
 A lot 45 28
Did you think it could be cancer?
 No 105 65
 Yes 57 35
Seeking attention
 Immediately 12 7
 Soon but not immediate 18 11
 Took some time 65 40
 Took a long time 67 41
What did the first doctor tell you?
 Benign tumor 40 28
 Tumor suspect 90 63
 Malignant tumor 13 10
Tests requested by the first doctor
 Ultra sound scan 78 48
 Mammograph 13 8
 Biopsy 50 31
 None 21 13
Table 3 Patient delay categories
a Six missing outcome data
Numbera Proportion Proportion 95 % CI
≤3 months 17 11 6–16
>3 months 139 89 84–94
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Table 4 The results of logistic regression analysis on patient delay
Variable Delay outcome OR (95 % CI) p value
No delay Delay
Number (%) Number (%)
Age group in years
 <35 1 (6) 31 (22) Reference
 35–44 8 (47) 40 (29) 0.16 (0.02–1.35) 0.093
 45–55 5 (29) 34 (25) 0.22 (0.02–1.98) 0.177
 >55 3 (18) 33 (24) 0.35 (0.04–3.60) 0.381
Religion
 Catholic 6 (35) 45 (33) Reference
 Muslim 2 (12) 14 (10) 0.93 (0.17–5.16) 0.937
 Pentecostal 5 (29) 30 (22) 0.80 (0.22–2.86) 0.731
 Protestant 4 (24) 46 (33) 1.53 (0.41–5.80) 0.529
 SDA 0 3 (2) – –
Marital status
 Single 4 (25) 16 (12) Reference
 Married 6 (38) 76 (55) 3.17 (0.80–12.53) 0.100
 Widowed 3 (19) 21 (15) 1.75 (0.34–8.95) 0.502
 Divorced 3 (19) 25 (18) 2.08 (0.41–10.56) 0.375
Employment
 Unskilled worker 5 (29) 30 (22) Reference
 Subsistence farmer 4 (24) 48 (35) 2.00 (0.50–8.04) 0.329
 Formal employment 7 (41) 19 (14) 0.45 (0.13–1.63) 0.226
 Unemployment 1 (6) 42 (30) 7.00 (0.77–63.02) 0.083
Number of children
 None 3 (18) 9 (6) Reference
 1–3 9 (53) 69 (50) 2.56 (0.58–11.22) 0.214
 ≥4 5 (29) 61 (44) 4.07 (0.83–20.01) 0.084
Education level
 None 1 (6) 14 (10) Reference
 Primary 3 (18) 48 (35) 1.14 (0.11–11.87) 0.911
 Secondary 3 (18) 53 (38) 1.26 (0.12–13.08) 0.845
 Tertiary 10 (59) 24 (17) 0.17 (0.02–1.49) 0.109
Monthly income (shillings)
 ≤93,750 5 (29) 64 (46)
 > 93,750 12 (71) 74 (54) 0.48 (0.16–1.44) 0.191
History of familial breast cancer
 No 11 (65) 104 (75)
 Yes 6 (35) 35 (25) 0.62 (0.21–1.79) 0.375
History of benign breast disease
 No 13 (76) 114 (82)
 Yes 4 (24) 25 (18) 0.71 (0.21–2.37) 0.581
How serious symptom considered
 Nothing serious 4 (24) 72 (52) Reference
 Little serious 3 (18) 24 (17) 0.44 (0.09–2.13) 0.310
 Moderately serious 0 10 (7) – –
 Very serious 10 (58.82) 33 (24) 0.18 (0.05–0.62) 0.007
Did you think it could be cancer
 No 6 (35) 96 (69)
 Yes 11 (65) 43 (31) 0.24 (0.08–0.70) 0.009
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We also found that patients who interpreted the breast 
symptoms as cancer were less likely to delay. However, 
patients who took the symptoms as nothing serious, 
delayed for more than 3 months. Patients’ interpretation 
of symptoms as not serious has proved to be strongly 
associated to patient delay in other quantitative studies in 
Germany and UK [2, 7].
In this study, only one patient had her breast problem 
detected through clinical breast examination. This indi-
cates the lack or frequency of clinical breast examination.
Patients who have heard of mammography were less 
likely to delay in this study. In a study done in Uganda 
published in 2010, it was mentioned that women in 
Uganda had little knowledge about mammography prob-
ably due to limited mammography services in Uganda 
[19].
Use of alternative care like herbal medicine with a bor-
derline p value of 0.055 may in part explain some of the 
delay seen in this study. It has been mentioned in previ-
ous studies that strong beliefs in traditional medicine 
and perhaps strong religious beliefs in LIC were the main 
reasons for delay in presentation [20–22]. In our study 
nearly half of the patients used herbal medicine prior to 
seeking conventional hospital based care.
Age, education level, marital status, socioeconomic 
status, history of breast disease, family history of breast 
cancer, nature of first symptom had no significant cor-
relation with patient delay. This contrasts with findings 
from other studies where socio-demographic factors 
were strongly associated with delay [10, 19], perhaps we 
needed a larger sample size.
Study limitations
This study was not free of limitations, some participants 
were not able to remember the exact time of onset of first 
breast, the time the first medical advice was obtained, the 
type of health worker first consulted, the date of referral 
and treatment given. However, calenders were used as an 
aid to remind patients of the dates accordingly.
Our participants were patients attending the breast 
clinic at a tertiary hospital in the country capital, hence 
might not be representative of the Ugandan women 
population though the demographic analysis reflects the 
country ethnic mix.
We focused on patient delay factors and not system 
factors, in some instances, it may be impossible to delink.
Conclusion
Patient delay is a very serious health problem that needs 
to be addressed urgently in Uganda. The delay was sig-
nificantly associated with lack of social support from 
spouses and close family members.
Table 4 continued
Variable Delay outcome OR (95 % CI) p value
No delay Delay
Number (%) Number (%)
Had knowledge of available services 6 (38) 99 (72) 4.23 (1.44–12.43) 0.009
Travel long distance from home 2 (13) 39 (28) 2.76 (0.60–12.70) 0.193
Had alternative care 4 (25) 71 (51) 3.18 (0.98–10.34) 0.055
Had fear of surgery 3 (19) 33 (24) 1.36 (0.37–5.07) 0.645
Lacked support 8 (50) 121 (88) 7.12 (2.36–21.46) 0.001
What did first doctor tell you
 Benign tumor 1 (6) 37 (31) Reference
 Tumor suspect 13 (81) 74 (61) 0.15 (0.02–1.22) 0.077
 Malignant tumor 2 (13) 10 (8) 0.14 (0.01–1.65) 0.117
Had antibiotic prescribed 9 (52.94) 97 (69.78) 2.05 (0.74–5.69) 0.166
Had prior Breast examination 7 (41.18) 21 (15.11) 0.25 (0.09–0.74) 0.012
Did self examination 11 (64.71) 70 (50.36) 0.55 (0.19–1.58) 0.269
Ever heard of mammogram
 No 10 (58.82) 118 (84.89)
 Yes 7 (41.18) 21 (15.11) 0.25 (0.09–0.74) 0.012
Manchester clinical stage
 Stage 2 3 (17.65) 3 (2.16) Reference
 Stage 3 3 (17.65) 13 (9.35) 4.33 (0.57–33.12) 0.158
 Stage 4 11 (64.71) 123 (88.49) 11.18 (2.01–62.13) 0.006
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Health education programs regarding breast cancer 
should address social support, provide more informa-
tion about the variability of breast cancer symptoms and 
encourage breast self examination and clinical breast 
examination.
Another study with a bigger sample size can be done 
over a longer period of time so that stronger conclusion 
can be made.
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